Daniel R. Twardzik

Statistics

Publications

Citations

8.3K

H-Index

Active since

1972

Affiliations

OncoGenex Pharmaceuticals (United States)(Current)

Bristol-Myers Squibb (United States)

University of Washington

National Cancer Institute

The University of Texas at San Antonio Health Science Center

Daniel R. Twardzik is an author at OncoGenex Pharmaceuticals (United States) specializing in life sciences, growth factor signaling, and signal transduction.

Publications per year

1972–2002

Publications

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor <i>β</i>

A. Hildebrand, Lars Melholt Rasmussen, Dick Heinegård et al. · Biochemical Journal · 1994 · 988 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Production of transforming growth factor beta 1 during repair of arterial injury.

Mark W. Majesky, Volkhard Lindner, Daniel R. Twardzik et al. · Journal of Clinical Investigation · 1991 · 533 citations · Full text

Medicine, Cardiology, Regenerative Medicine +10

Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets

Ronald L. Heimark, Daniel R. Twardzik, Stephen M. Schwartz · Science · 1986 · 435 citations

Life Sciences, Cell Biology, Molecular Biology +17

Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape Mechanism

Manoel Barral‐Netto, Aldina Barral, C E Brownell et al. · Science · 1992 · 433 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

<i>In vivo</i> induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain

James Fallon, Steve G. Reid, R. Kinyamu et al. · Proceedings of the National Academy of Sciences · 2000 · 426 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

1–5 of 58